初次与翻修全膝关节置换术中出血与止血优化:结构化专家意见调查
该调查基于14名关节置换专科医生,围绕初次与翻修全膝关节置换术中破坏性出血的定义、危险因素、升级标准及止血剂使用达成专家意见。专家支持以临床有意义的事件复合定义破坏性出血,而非单纯依赖失血量或血红蛋白下降等定量指标,常规预防性使用局部止血剂在初次全膝关节置换术中未获支持,翻修术中可选择性使用。
要点
- 破坏性出血应定义为需改变临床管理的事件复合终点,而非孤立数值指标。
- 血小板减少和抗凝药物使用被全部14名专家视为重要危险因素。
- 初次全膝关节置换术不推荐常规预防性使用局部止血剂,翻修术可选择性使用。
核心结论
- 破坏性出血被视为由改变临床管理的事件构成的复合概念,而非孤立的失血量数值指标。
- 该发现为探索性、假设生成框架,尚需多学科和数据驱动的验证。
研究设计与样本
- 基于调查的研究,纳入14名接受过专科培训且具有初次和翻修全膝关节置换术经验的关节置换外科医生。
- 调查领域包括危险因素、破坏性出血定义、术中出血模式、术后引流评估、升级标准和局部止血剂使用;条目高度一致 predefined 为≥70%一致。
主要发现
- 受访者支持将破坏性出血定义为临床有意义结局的复合指标,而非孤立定量指标。
- 一致同意纳入操作指标(有症状的血红蛋白下降大于3 g/dL和持续伤口引流)和下游事件(输血、再手术、栓塞和再入院)。
- 血小板减少和抗凝药物使用是重要危险因素(14/14),其次为凝血病和肝病(12/14)。
关键数值与推荐
- 升级触发因素包括疑似动脉出血(14/14)、扩大的血肿(13/14)、血流动力学不稳定(13/14)、神经血管受损(13/14)和术后第5天以后引流(12/14)。
- 初次全膝关节置换术不推荐常规预防性使用局部止血剂(2/14),翻修病例中可选择性支持使用(7/14)。
临床怎么用
- 临床中可将破坏性出血视为需改变管理的事件复合终点,结合操作指标和下游事件进行监测与升级决策。
- 对血小板减少、抗凝药物使用、凝血病和肝病患者应加强出血风险评估。
- 出现疑似动脉出血、扩大的血肿、血流动力学不稳定、神经血管受损或术后第5天以后引流时应考虑升级干预。
- 初次全膝关节置换术不常规预防性使用局部止血剂,翻修术可选择性使用。
局限性
- 样本量小(14名外科医生),为探索性、假设生成框架,需多学科和数据驱动验证。
- 引流阈值和干预时机仍存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disruptive bleeding following total knee arthroplasty (TKA) continues to affect postoperative recovery despite advances in perioperative blood management, with wound drainage and dressing-related findings common clinical concerns. Conventional definitions based on estimated blood loss or hemoglobin decline may not capture bleeding events that alter clinical management. This study sought to establish agreement on disruptive bleeding in TKA and identify clinically relevant factors guiding monitoring, escalation, and hemostatic decision-making. METHODS: A survey-based study was conducted among 14 fellowship-trained arthroplasty surgeons who had experience in primary and revision TKA. Domains included risk factors, definitions of disruptive bleeding, intraoperative bleeding patterns, postoperative drainage assessment, escalation criteria, and the use of topical hemostatic agents. Responses included Likert-scale ratings, categorical selections, and free-text data. High agreement for items was defined a priori as ≥ 70% agreement. RESULTS: Respondents supported defining disruptive bleeding as a composite of clinically meaningful outcomes rather than isolated quantitative measures. There was unanimous agreement to include operational indicators (symptomatic hemoglobin decline greater than three g/dL and persistent wound drainage) and downstream events (transfusion, reoperation, embolization, and readmission). Thrombocytopenia and anticoagulant use were important risk factors (n = 14 of 14), followed by coagulopathy and liver disease (n = 12 of 14). Escalation triggers included suspected arterial bleeding (n = 14 of 14), expanding hematoma (n = 13 of 14), hemodynamic instability (n = 13 of 14), neurovascular compromise (n = 13 of 14), and drainage beyond postoperative day five (n = 12 of 14). Routine prophylactic use of topical hemostatic agents was not supported in primary TKA (n = 2 of 14), but was selectively favored in revision cases (n = 7 of 14). Variability remained regarding drainage thresholds and timing of intervention. CONCLUSIONS: Disruptive bleeding in TKA was viewed as a composite construct defined by events that alter care rather than isolated numeric blood-loss measures. These findings represent an exploratory, hypothesis-generating framework requiring multidisciplinary and data-driven validation.
引用
- Chen AF, Mont MA, Smitterberg CW, et al. Bleeding and Hemostasis Optimization in Primary and Revision Total Knee Arthroplasty: A Structured Expert-Opinion Survey. J Arthroplasty. 2026. PMID: 42855015. doi:10.1016/j.arth.2026.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。